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Abstract
Introduction: The susceptibility to adverse outcome from critical injury (occurrence of sepsis, septic shock, organ
dysfunction/failure, and mortality) varies dramatically due to different degrees of inflammatory response. We
assessed the relationship of the genotype distribution of various cytokine gene polymorphisms (CGP) with regard
to the development of sepsis, organ dysfunction or mortality in severely injured patients.
Method: Observational, hospital-based cohort study of 114 severely injured North Indian patients from New Delhi
admitted to the Emergency Department (ED) of Trauma Centre, AIIMS. Patients were monitored from day first
to discharge or death, measuring SOFA score, sepsis and septic shock occurrences up to one month. We have
analyzed 13 cytokine genes, including the SNPs of structural and regulatory regions at 22 positions.
Results: Sequence-specific primer based PCR indicated that eight polymorphic loci IL-1α /-889, IL-1β/-511, IL-1R
(pstI 1970), TGF-β/ code 10, TNF-α/-308, TNF-α/-238, IL-6/+565 and IL-10/-1082, out of 22 SNPs are significantly
associated with sepsis morbidity and outcome. Theses SNPs might be used as risk determinants of the outcome.
Patients with IL-10 (−1082A/A) genotypes were found significantly higher in post traumatic sepsis patients and had
a significantly higher risk to developed sepsis complication (p < 0.05, OR = 0.86, C.I = 0.08-8.8).In case of TNF-α (−308)
position, GA and GG genotype patients have a significantly lower risk of poor outcome (p < 0.05, OR = 0.25,
C.I = 0.01-1.3) and (p < 0.05, OR = 0.22, C.I = 0.01-0.5) in comparison to AA genotype. In this study, two
polymorphisms (IL-1β (−511) and IL-1R) were significantly associated with the development of MOF and
mortality, where as IL-1α (−889) polymorphism associated with susceptibility for sepsis. The distribution of
haplotypes of TGF-β and IL-6 were also associated with sepsis susceptibility and outcome.
Conclusion: In conclusion, we have found that the alternations in the genotype and allele frequency of IL-1β
(−511C/T), TNF-α (−308 G/A), TNF-α (−238 G/A) and IL-10 (−1082 G/A) genes are associated with an higher
risk of sepsis development in trauma patients and outcomes.
Introduction
Despite tremendous advancements in pre-hospital system
and treatment in hospitals, trauma emerged as the fourth
leading cause of death among all diseases worldwide [1, 2].
Posttraumatic sepsis as a result of hysterical immune
inflammatory responses is one of the leading sequential
dysfunction of vital organs and most commonly seen
problems associated with the ICU [3, 4]. Though there
have been many advances in the development of antibiotics
and caring care, sepsis remains a solemn and deadly prob-
lem with high mortality rates worldwide [5]. Therefore,
prognostic markers to identify high-risk patients are imme-
diately needed for early detection and preventive care of
sepsis. Cytokines play vital roles in the regulation of host
immune response, and distorted expression of cytokines
are proven to be involved the development of sepsis [6].
Previous studies suggests that variations in the genes en-
coding cytokines are also involved in the inflammatory
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responses and are responsible for inter-individual differ-
ences in susceptibility to sepsis and its severity [7, 8]. De-
lineating the variations in cytokine genes and associated
differences in response to sepsis might contribute to
the development of new genetically modified diagnos-
tic and therapeutic interventions that may improve
outcome in post traumatic sepsis patients. According
to the biphasic model of trauma etiology, derange-
ment of both pro-inflammatory as well as anti-
inflammatory immune responses eventually culminates
into sepsis associated mortalities [9].
Reasons associated with the above mentioned
conditions are under meticulous investigations, but
numerous studies has advocated the significance of
genetic variations (particularly single nucleotide poly-
morphisms) as key determinants of inter-individual
variations in both inflammatory responses and clinical
outcome in trauma patients [10, 11] . Single nucleo-
tide polymorphism (SNPs) are the key factors that
regulate the expressional variation of human genes
and found to be associated with the susceptibility and
progression [12]. Studies of TNF-α gene polymor-
phisms at position −308 and −238 have been reported
within the promoter region, and showed susceptibility
and resistance between population [7, 13]. Interest-
ingly, IL-6 (−174 G/C) polymorphism influenced the
immune pathogenesis of sepsis in European popula-
tions of trauma [14]. Ryan et al. (2013) studied the
cytokine gene polymorphism and outcome after traumatic
brain injury in population of the United Kingdom and
observed polymorphism associated with resistance to
sepsis and outcome [15]. Polymorphisms at IL-10 pro-
moters:-1082 (G/A), −819 (C/T) and −592 (C/A) are asso-
ciated with resistance to sepsis in Caucasians population
[16, 17] . Interleukin (IL-1) gene complex polymorphism
associated susceptibility for sepsis was studied in trauma
patients of Chinese population [7, 8].
Contemplating it, we evaluated the polymorphisms in
fallowing cytokine genes; interleukin IL-1-α (T/C-889),
IL-1-β (−511 C/T, T/C + 3962), IL-1RA (T/C mspal1100),
IL-4RA (G/A + 1902), IL-12 (C/A-1188), IFN-γ (+874
A/T), TGF-β1 (C/T codon10, G/C codon25), TNF-α
(G/A −308, G/A −238), IL-2 (T/G −330 G/T +166),
IL-4(T/G-1098, T/C-590, T/C-33), IL-6 (G/C −174, G/
A nt 560), IL-10 (G/C −1082, C/T −819, C/A −592)
in trauma hemorrhagic shock (THS) patients with re-
spect to their secretary levels. The major goal of this
study: (1) To find out cytokine gene polymorphism
found in trauma patients who had developed sepsis
with non-sepsis as well as survivors with non-
survivors to unravel their role in the predisposition of
disease progression, (2) to evaluate the SNP-SNP
interaction of cytokine gene polymorphisms with re-
spect to their expression in serum of trauma patients.
We observed significant association of TNF-α -238 (AA),
IL-1α-889 (CC) and IL-10-1082(GG) genotype in sepsis and
IL-1β -511 (CT), IL-1RpstI1970 (TT) and TGFβ codon25 (GG)
genotype in non-survivors. Interestingly, these genotypes
are present in trauma patients, thus shedding some light
on the predisposition to the progression of sepsis and also
from non-sepsis to sepsis. However,TNF-α -238(AA), IL-
1α-889(CC) and IL-10-1082(GG) genotypes appeared to be a
higher producer by CBA assay, but IL-10 masked the ex-
pression of the high producing genotype of TNFα -238(AA)
in sepsis patients. Expressions masking of TNF-α was
found to be linked with the degree of IL-10 presence in
sepsis patients.
Materials and methods
Patient evaluation and ethics
This study was approved by the institute ethics com-
mittee/ethics sub-committee of All India Institute of
Medical Sciences, New Delhi, India (Ref.No.IESC/T-358/
30.09.2011). Patients of either sex (16–60 years old) with
systolic blood pressure (SBP ≤90 mm Hg), olingourea or
no urine output, presenting within the 8 h of trauma were
recruited after taking the consent from the patient’s or
their relatives. Those patients who had neurogenic shock,
traumatic brain injury (TBI), septic shock and already re-
suscitated with anti-inflammatory drugs or corticosteroids
before reporting to the Emergency Department (ED) were
excluded from this study.
Patients in whom blood sampling was not initiated
within the first 8 h after a trauma were also excluded
from this analysis. Severity was assessed by Injury sever-
ity score (ISS) and Shock Index (S.I) in the ED and
development of organ dysfunction was assessed by the
Sequential Organ Failure Assessment score (SOFA;
range, 0–24). Mortality was defined as death occurring
till 30 days after the onset of hemorrhagic shock.
Patients were classified as survivor if they were dis-
charged alive from the ICU. Further, we have categorized
the patients into two broad categories, those who devel-
oped sepsis complication and other those who did not
during the 30 days of observational period.
All patients requiring surgical intervention received
standard surgical care and postoperative intensive care
unit treatment. Blood samples were drawn within 8 h
after admission (designated day 0) and immediately used
for DNA extraction for PCR-SSP assay.
Sample collection
Collection of first blood sample
All patients were managed according to the protocol
of the American College of Surgeons Advanced
Trauma Life Support (ATLS). Patients were stabilized
(SBP = 105 mmHg) with crystalloids or colloids before
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collecting the blood sample, which is collected on the
spot in the Emergency Department (Day 0).
Blood samples were also collected from 140 healthy,
age matched, uninjured individuals who formed the con-
trol group for DNA extraction and CGP analysis after
taking the proper consent form from the patients.
Definitions, scoring of severity and outcome
Abbreviated injury scale (AIS) score of traumatic in-
juries induced while living and diagnosed by autopsy
were determined using the 1985 protocol of the
American Association for Automotive Medicine [18].
AIS scores range from 1 to 6; total AIS scores, which
represent the sum of scores for each body region
(head and neck, face, chest, abdomen, extremities and
external) and the ISS [18], which is defined as the
sum of the square of the single highest AIS score in
each of the three most severely injured body regions
were determined for each case. Shock Index (S.I) is
the ratio of Heart rate and Systolic blood pressure
(SBP) were calculated for every patient in ED to
understand the extent of hemorrhagic shock.
The SOFA score is used to track a patient’s status during
the stay in the ICU. The SOFA score is a scoring system
to determine the extent of a person’s organ function or
rate of failure [3, 19]. The score is based on six different
scores, one each for the respiratory, cardiovascular,
hepatic, coagulation, renal and neurological systems.
Emphasizing on the potential prognostic value of the
serum cytokines, evaluated the correlation with the injury
severity and SOFA score.
Systemic Inflammatory Response Syndrome (SIRS)
The systemic inflammatory response to a wide variety of
severe clinical insults, manifested by two or more of the
following conditions: (1) Temperature > 38 °C or < 36 °C,
(2) Heart rate > 90 beats/min, (3) Respiratory rate > 20
breaths/min or PaCO2 < 32 mmHg, (4) WBC count >
12,000/mm3, < 4000/mm3, or > 10 % immature (band)
forms.
Sepsis
The systemic inflammatory response to infection. In as-
sociation with infection, manifestations of sepsis are the
same as those previously defined for SIRS. It should be
determined whether they are a direct systemic response
to the presence of an infectious process and represent
an acute alteration from baseline in the absence of other
known causes of such abnormalities. The clinical mani-
festations would include two or more of the following
conditions as a result of a documented infection.
Multiple Organ Dysfunction Syndromes (MODS)
The presences of altered organ function in severe
trauma patient such that homeostasis cannot be main-
tained without intervention.
SNP selection
To investigate the genotype, we have selected IL-2,
IL-12, IFN-γ, and TNF-α, IL-1α, IL-1β as pro-
inflammatory cytokines and TGF-β, IL-4 and IL-10 as
anti-inflammatory cytokine genes for studying genetic
or SNP-SNP interaction. The receptor chain of IL-1R,
IL-1Ra, IL-4R was also selected to find out the under-
lying functional discrepancy in the trauma patients.
SNPs were selected according to the priority of minor
allele frequency (5 %) publicity available database
selected from the National Centre for Biotechnology
Information (NCBI) Entrez SNP (build 36) and the
International HapMap project: Han Chinese (Asian
population). Few of the SNPs were included either on
the basis of their functional role, as demonstrated or
putative and well documented in the literature.
Genotyping of SNPs for the cytokine genes
Total 10 mL venous blood from each trauma patients
and healthy volunteers were collected. 5 mL of blood
in EDTA vials was subjected to PCR-SSP assay, while
another 5 ml collected with (no anticoagulant) was
used for cytokine analysis by CBA. DNA was
extracted by standard phenol-chloroform method, and
stored at −80 °C, till further use. Samples showing
260/280 ratio as 1.82-1.86 were only used for the
PCR-SSP analysis. Afterwards, above DNA was sub-
jected to in vitro amplification using Cytokine CTS-
PCR-SSP tray Kit (Heidelberg, Germany) according to
manufacturer’s instructions. Each PCR tray of this kit
is meant for two different samples. Each well contains
two different primers: one for specific polymorphism
and other for positive control. We run all the samples
in duplicates. Amplified products were transferred
onto 2 % agarose gel and electrophoresed at 100 V
for 55 min to get the maximum resolution of poly-
morphic bands. As an internal positive control, a
fragment of human globin gene (440 bp) for ampli-
cons lanes containing IL-1α, IL-β, IL-1R, IL-4R, IL-
12, IFN-γ, TGF-β and TNF-α (1–26 lanes of the gel)
were co-amplified with a control of globin gene
(440 bp) in the same well, while the lane containing
amplicons of IL-2, IL-4 and IL-10 (27–48 lanes of the
gel) were co-amplified with human C reactive protein
gene (90 bp) as control. Representative gel picture for
distribution of genotypes and alleles along with in-
ternal controls CRP gene (89 bp) and β-globulin gene
(440 bp) are shown in (Fig 1).
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Statistical analysis
Statistical analyses were performed using STATA 11.2
(SPSS Inc., Chicago, IL, USA) and Graph Pad Prism 5.0
(Graph Pad Software, San Diego, CA, USA). Categorical
data were compared using chi square (χ2) and continu-
ous data were compared by the Mann–Whitney U test.
Allele frequencies were obtained through direct count-
ing. Odds ratio (OR) with 95 % confidence intervals
(95 % CI) was also calculated using the same software. A
p-value of <0.05 was considered statistically significant.
Hardy-Weinberg equilibrium was used for each SNP
employing Arle-quin software version 3.1. Univariate
and Multivariable logistic regression was used to calcu-
late the unadjusted and adjusted odds ratio for evaluat-
ing effects of genotype on mortality and sepsis.
Results
Outcome and clinical variables
Out of 130 patients enrolled in this study, 16 patients
died within 24 h in the hospital were excluded from ana-
lysis. The age (mean ± SD) of 114 patients (96 male and
16 female) were 34.3 ± 14.5 years. Of the 114 patients,
77 (67.5 %) survived and 37 (32.5 %) were died after
injury by one month (Table 1). The demographic and
clinical data of 114 patients included in the study was
shown in (Table 1) where as demographic and clinical
data for the survivors and non-survivors were sum-
marized in (Table 2). The age, gender and S.I were
comparable between survivors and non-survivors. The
SOFA and ISS score of non-survivors were signifi-
cantly (p < 0.001) higher in comparison to survivors
(Table 2). SOFA score of non-survivors were signifi-
cantly (p < 0.001) higher with mean value 7.2 ± 2.3 and
10.3 ± 1.15 on day 7th and 14th respectively (Table 2). In
this study, 25 patients (18 male & 7 female) developed
sepsis within 30 days. The SOFA score, ISS score and
gender were significantly differ between patients with
sepsis and non-sepsis (Table 3).
Fig. 1 A representative 2 % agarose gel diagram of a battery of pro and anti-inflammatory cytokine gene variants. Each of the primer mixes contained
a non-allelic internal control primer pair, which amplified either a part of the β-globin gene (440 bp amplicon) in upper row or a part of the C-reactive
protein gene (CRP) at 89 bp in lower row
Table 1 Clinical characteristics of trauma victim with hemorrhagic
shock patients (n = 114)
Number Percent
Age (yrs), mean ± sd 34.3 ± 14.5
(16–60)
Male/Female 98/16




ISS (Injury severity scale) 18.71 ± 8.48




Three or above 12 10.5
Cause of trauma
Traffic accident 82 71.9
Free fall from a height 17 14.9
Heavy weight blunts Injury 15 13.1
Survival 77 67.5
Death 37 32.5
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Cytokine gene polymorphism in patients and controls
We have recruited the 114 homogeneous north Indian
patients with hemorrhagic shock in this study, and mea-
sured the distribution of genotype and allele frequency
and correlated with 140 north Indian healthy controls.
There was no significant (p ˃ 0.05) changes in distribu-
tion of genotype and allele frequency between these
groups Additional file 1: Table S1.
Cytokine gene polymorphism in post traumatic sepsis vs.
non-sepsis patients
In this study, 25 patients (18 male & 7 female) developed
sepsis within 30 days. The distribution of genotype and
allele frequency of cytokine genes that were not significant
in two groups are shown in Additional file 2: Table S2
where as significantly observed distribution between these
groups are shown in (Table 4). On univariate logistic re-
gression analysis, the distribution of genotypes at positions
IL-1α (−889 C/T), IL-4 (−1098 T/G), IL-10 (−1082 A/G),
allele A of TNF-α (−238) and allele T of IL-10 (−889) were
significantly (p < 0.05) predominant in sepsis (Table 4).
The SOFA score, ISS score and gender were signifi-
cant (p < 0.05) in these groups (Tables 2 and 3). Further,
we calculated the adjusted odds ratio after adjusting for
SOFA, ISS and gender using a multivariate logistic regres-
sion model in both groups (Table 5).
The IL-1 gene polymorphism corresponding to IL-1α
(−899), IL-β (−511) and IL-1β (+3962) were analyzed
between patients with sepsis and non-sepsis. However,
significant (p < 0.05) differences in distribution of geno-
type and allele frequency were observed for IL-1α (−899)
Table 2 Clinical characteristics of survivors and non-survivors
patients
Survivors Non-survivors P value
Patients n = 77 n = 37
Sex (M/F) 65/12 33/4 0.35
Age (yrs) 33.7 ± 14.4 35.6 ± 14.8 0.26
ISS 15.2 ± 6.4 26.1 ± 7.3 0.02
S.I 1.14 ± 0.35 1.2 ± 0.74 0.43
SOFA-7 3.5 ± 1.57 7.2 ± 2.34 0.001
SOFA-14 5.2 ± 1.7 10.3 ± 1.15 0.001
M/F represents males and females. ISS and S.I represent Injury severity scale
and Shock Index
SOFA-7 and SOFA-14 represents the sequential organ failure assessment score
on day 7 and 14
Table 3 Clinical characteristics of patients with sepsis and
non-sepsis
Sepsis Non-sepsis P value
Patients n = 25 n = 89
Sex (M/F) 18/7 72/17 0.02
Age (yrs) 37.5 ± 16.1 33.4 ± 13.9 0.21
ISS 21.2 ± 6.8 18 ± 8.8 0.05
S.I 1.2 ± 0.44 1.16 ± 0.53 0.5
SOFA-7 5.28 ± 1.96 3.78 ± 2.34 0.006
SOFA-14 7.86 ± 2.18 4.77 ± 2.31 0.0001
Mortality
n (%) 16(64) 21(29.5) 0.001
M/F represents males and females. ISS and S.I represent Injury severity scale
and Shock Index
SOFA-7 and SOFA-14 represents the sequential organ failure assessment score
on day 7 and 14
Table 4 Genotypic and allelic frequency distribution in patients
with sepsis and non-sepsis
Cytokine gene
polymorphism
Genotype Non-sepsis Sepsis p value OR (95 % CI)
f (%) f(%)
n = 89 n = 25
IL-1α(−889) CC 45(50.56) 21(84) 1
TC 32(35.96) 3(12) 0.01 0.20(0.05–0.73)
TT 12(13.48) 1(4) 0.17(0.02–1.4)
C 122(68.5) 45(90) 1
T 56(31.5) 5(10) 0.002 0.24(0.07-0.6)
TNF-α(−308) AA 3(3.3) 2(8) 1
GA 17(19.1) 1(4) 0.09 0.08(0.05–1.3)
GG 69(77.6) 22(88) 0.47(0.07–3.0)
A 23(13) 5(10) 1
G 155(87) 45(90) 0.57 1.3(0.46–4.7)
TNF-α(−238) GG 78(87.7) 19(76) 1
GA 10(11.2) 4(16) 0.13 0.2 (0.13–2.8)
AA 1(1.1) 2(8) 0.12(0.01–1.4)
G 166(93.2) 42(84) 0.04 1
A 12(6.8) 8(16) 2.6(0.87–7.5)
IL-4(−1098) TT 66(74.1) 12(48) 1
TG 21(23.6) 9(36) 0.006 2.3(0.87–6.3)
GG 2(2.3) 4(16) 11(1.8–66.9)
T 153(86) 33(82) 0.001 1
G 25(14) 17(18) 3.1(1.4–6.8)
IL-10(−1082) GG 5(5.7) 4(16) 1
GA 33(37) 2(8) 0.01 0.07 (0.01–0.52)
AA 51(57.3) 19(76) 0.46 (0.11–1.9)
G 30(16.9) 10(20) 0.60 1
A 148(83.1) 40(80) 0.8(0.34–2.0)
IL-10(−819) CC 63(70.7) 16(64) 1
CT 22(24.7) 6(24) 0.39 0.10 (0.03–3.0)
TT 4(4.6) 3(12) 0.65 (0.14–2.9)
C 148(83.1) 12(76) 0.001 1
T 30(16.9) 31(24) 12.7(5.5–30.1)
Gupta et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2015) 23:96 Page 5 of 13
position. At this position three genotypes CC, TC and
TT were analyzed in both groups. The frequency of CC.
TC and TT genotype in patients with sepsis and non-
sepsis were 84 % vs. 50.5 %, 12 % vs. 36 % and 4 % vs.
13.4 % (p < 0.05) respectively (Table 4). Interestingly, we
noticed patients with TC genotype had significantly
lower risk of developing sepsis as compared to homozy-
gous genotypes CC and TT (p = 0.01, OR (95 %) =0. 21,
CI = 0. 05–0.79). The allele frequency of C among sepsis
(90 %) was significantly higher as compared to non-
sepsis (68.5 %, p = 0.002). However, the adjusted odd ratio
TC genotype at this position were 0.21 times, lowered in
comparison to CC genotype (p = 0.02, CI = 0.05-0.79)
(Table 5).
The TNF-α gene has a biallelic polymorphism in the
promoter region at position −308 and −238, representing
G to A transitions were studied in both groups (Table 4).
The genotype frequency at −238 position were 76 % vs.
87.7 % for AA, 16 % vs. 11.2 % for GA and 8 % vs. 1.1 %
for GG in patients with sepsis and non-sepsis respect-
ively (Table 4). On univariate logistic regression ana-
lysis, the allelic frequency of allele A were 2.6 times
higher odd to develop sepsis (p = 0.04, OR (95 %) =2.6,
CI = 0.87-7.5) compared to non-sepsis patients (Table 4).
At position-308, the distribution of genotype frequency of
GG, GA and AA were comparable between two groups
(Table 5). The genotype frequency of GA in sepsis
(4 %) was comparatively lower than non-sepsis (19.1 %)
(p = 0.099, OR (95 %) =0.08 and CI = 0.05-1.3). At
(−1098 T/G) position of the IL-4 gene, we observed that
patients having GG genotypes had significantly (p = 0.009,
OR (95 %) =11, CI = 1.8-66.9) higher risk to develop sepsis
complications as compared to other two genotypes (TT
and TG). The allelic frequency of allele G in sepsis (18 %)
was found to be significantly (p = 0.001, OR (95 %) =3.1,
CI = 1.4-6.8) higher as compared to non-sepsis (14 %)
(Table 4).
Three well known SNPs were reported in IL-10
genes, two in promoter regions (−1082,-819) and an-
other in coding region (+592). However, we observed
skewed genotypes at −1082 positions only. The distri-
bution of genotypes frequency of GG, GA and AA
was found to be as 16 % vs. 5.7 %, 8 % vs. 37 % and
76 % vs. 57.3 % in patients with sepsis and non-sepsis
respectively (Table 5). Patients with GA genotype had
0.07 times lower odd to developed sepsis [OR (95 %
CI) :(0.01-0.52), p = 0.01]. Patients with allele T at IL-
10 (−819) had 12.5 times more chances of developing
sepsis as compared to non-sepsis (p = 0.001, OR
(95 % CI) = 12.5, CI = 5.5-30.1).
The distribution of haplotype of the TGF-β, TNF-α, IL-
2, IL-4, IL-6 and IL-10 genes were studied in patients with
sepsis and non-sepsis (Table 6). However, the distribution
of haplotypes in TNF-α and IL-10 genes were observed
significant (p < 0.05) in both groups. The frequency of GA
in patients with sepsis (8.0 %) was significantly higher as
compared to non-sepsis (0 %) (p < 0.05). Other haplotypes
GG and AG were comparable in both groups. Haplotype
Table 5 Distribution of genotypes in non-sepsis and sepsis patients using multivariate logistic regression analysis
Cytokine gene
polymorphism
Genotype Non-sepsis Sepsis Unadjusted odds ratio Adjusted odds ratio
f (%) f (%) OR (95 % C.I) p value OR (95 % C.I) p value
n = 89 n = 25
IL-α(−889) CC 45(50.56) 21(84) 1 1
TC 32(35.96) 3(12) 0.20(0.05–0.73) 0.01 0.21(0.05–0.79) 0.02
TT 12(13.48) 1(4) 0.17(0.02–1.4) 0.10 0.25(0.02–2.1) 0.20
TNF-α(−238) GG 78(87.7) 19(76) 1 1
GA 10(11.2) 4(16) 0.2 (0.13–2.8) 0.2 0.19(0.01–3.1) 0.2
AA 1(1.1) 2(8) 0.12(0.01–1.4) 0.09 0.09(0.007–1.3) 0.08
TNF-α(−308 AA 3(3.3) 2(8) 1 1
GA 17(19.1) 1(4) 0.08(0.05–1.3) 0.07 0.10(0.006–1.6) 0.10
GG 69(77.6) 22(88) 0.47(0.07–3.0) 0.43 0.64(0.09–4.6) 0.66
IL-4(−1098) TT 66(74.1) 12(48) 1 1
TG 21(23.6) 9(36) 2.3(0.87–6.3) 0.09 1.8(0.47–7.5) 0.36
GG 2(2.3) 4(16) 11(1.8–66.9) 0.009 6.1(0.58–64) 0.12
IL-10(−1082) GG 5(5.7) 4(16) 1 1
GA 33(37) 2(8) 0.07(0.01–0.52) 0.01 0.36(0.03–3.5) 0.38
AA 51(57.3) 19(76) 0.65(0.11–1.9) 0.29 1.9(0.33–11.5) 0.45
n (%) = number of subjects (expressed as percentage),OR = odds ratio, CI = class intervals
Adjusted odds ratio for ISS, SOFA score and gender
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ATA of IL-10 gene in patients with sepsis (16 %) was sig-
nificantly (p = 0.01) higher in comparison to non-sepsis
(1.2 %). However, haplotype ACC was found to be pre-
dominant in both groups. Other haplotype ACC and GCC
were observed similar in patients with sepsis and non-
sepsis (Table 6).
Cytokine gene polymorphism in non-survivors and survivors
patients
In this study, out of 114, 37(32.5 %) patients died within
30 days. On univariate logistic regression analysis, the
genotypes IL-1R (pst I 1970 T/T), IL-1β (−511 C/T) and
TGFβ (codon 25 G/G) and allele A of IL-12(−1188 C/A),
allele G of IL-4R(+1902) and allele T of IL-1R were pre-
dominant in non-survivors (Table 7). The genotype, which
was observed comparable in both groups of patients is
shown in Additional file 3: Table S3. We found signifi-
cantly higher SOFA and ISS score in non-survivors as
compared to survivors (Tables 2 and 3). Further, we calcu-
lated the adjusted odds ratio after adjusting for SOFA and
ISS score using a multivariate logistic regression model in
both groups (Table 8). The distribution of CC, CT and
TT genotype at IL-1β (−511) were observed signifi-
cant (p = 0.03) in both groups (Table 7). The odds of
finding of CT genotype was 2.7 times higher in non-
survivors as compared to survivors (p = 0.03, OR
(95 %) = 2.7 & CI = 1.0-7.1) (Table 7). The TT geno-
type of IL-1R (pst I1970) was significantly higher
compared to non-survivors (p = 0.05, OR (95 %) =5.0,
CI = 1.5-16.9) (Table 7). The allelic frequency of allele
T in non-survivors (52.7 %) was significantly (p = 0.01,
OR (95 %) =2.0 and CI = 0.62-2.5) higher as compared
to patients with survivors (35.8 %) (Table 7).
At IL-4R position, AA genotype in survivors (66.2 %)
was1.5 times higher compared to non-survivors (46 %)
(p > 0.05). The allele G was (p = 0.001, OR (95 %) =16.2
and CI = 7.7-34.7) four folds (79.8 %), higher in non-
survivors in comparison to survivors (19.5 %) (Table 7).
At position −1188, the distribution of 12.9 % vs. 8.1 %
for CC, 32.4 % vs. 24.3 % for CA and 54.7 % vs. 67.6 %
for AA (p = 0.49) was observed in survivors and non-
survivors patients (Table 7). The frequency of allele A in
non-survivors (79.8 %) was significantly (p = 0.01, OR
(95 %) =0.23 and CI = 0.12-0.44) higher as compared to
survivors (70.8 %) (Table 7).
In case of TGF-β, two SNPs, one at codo10 and an-
other at codon 25 were analysed in survivors and non-
survivors patients. However, the distribution of genotype
at codon 25 position was significant (p < 0.05) in both
groups. At this position, genotype observed were 79.2 %
vs. 70.2 % for CC, 18.2 % vs. 21.6 % for CG and 2.6 % vs.
8.1 % for GG in survivors and non-survivors respectively
Table 6 Distribution of haplotype in patient with sepsis and non-sepsis
Cytokine gene Haplotypes Distribution of haplotype in patients with sepsis and non-sepsis
Polymorphism Sepsis patients Non-sepsis patients χ2 p value
n (%) n (%)
TGF-β codon 10 C/T& codon25 G/C CG 19(76) 72(80.9)
CC 2(8) 1(1.1) 3.6 0.18
TG 4(16) 16(18.0)
TNF-α-308 G/A &-238 G/A GG 21(92) 86(96.7)
GA 2(8) 0(0) 8.0 0.05
AG 0(0) 3(3.3)
IL2 -330 T/G & + 160 G/T GG 6(24) 18(20.2)
TG 19(76) 65(73) 1.8 0.76
GT 0(0) 1(1.1)
TT 0(0) 5(5.7)
IL4-1098 T/G, −590 C/T & -590 C/T GCC 0(0) 2(2.2)
TCC 20(80) 70(78.6) 0.57 0.99
TTT 5(20) 17(19.2)
IL6-174 G/C & + 565 A/G GG 24(96) 86(96.6) 0.50 0.63
CG 0(0) 1(1.1)
GA 1(4) 2(2.3)
IL10 -1082 G/A, −819C/T &-592 C/A GCC 8(32) 30(33.7)
ACC 13(52) 58(65.1) 10.4 0.01
ATA 4(16) 1(1.2)
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Survivors Non-survivors p Value OR (95 % CI)
n (%) n (%)
n = 77 n = 37
IL-1β(−511) CC 34(44.1) 9(24.4) 1
CT 27(35) 20(54) 0.03 2.7(1.0–7.1)
TT 16(20.9) 8(21.6) 1.8(0.61–5.8)
C 95(83.3) 38(51.3) 0.13 1
T 59(16.7) 36(49.7) 1.5(0.83–2.7)
IL-1R(pst I 1970) CC 29(37.6) 9(24.3) 1
CT 41(53.2) 17(45.9) 0.02 1.3(0.52–3.4)
TT 7(9.0) 11(29.8) 5.0(1.5–16.9)
C 99(64.2) 35(47.3) 0.01 1
T 55(35.8) 39(52.7) 2.0(1.0–3.6)
IL-4R(+1902) AA 51(66.2) 17(46) 1
GA 22(28.6) 16(43) 0.08 2.1(0.93–5.0)
GG 4(5.2) 4(11) 3(0.67–13.3)
A 124(80.5) 15(20.2) 0.001 1
G 30(19.5) 59(79.8) 16.2(7.7–34.7)
IL-12(−1188) CC 10(12.9) 3(8.1) 1
CA 25(32.4) 9(24.3) 0.49 1.2(0.26–5.3)
AA 42(54.7) 25(67.6) 1.9(0.49–7.9)
C 45(29.2) 47(20.2) 0.001 1
A 109(70.8) 27(79.8) 0.23(0.12–0.44)
TGF-β(codon25) CC 61(79.2) 26(70.27) 1
CG 14(18.2) 8(21.62) 0.04 1.3(0.50–3.6)
GG 2(2.6) 3(8.1) 3.5(0.55–22.3)
C 136(88.3) 60(81.1) 0.14 1
G 18(11.7) 14(18.9) 0.56(0.24–1.3)




Genotype Survivors Non-survivors Unadjusted odds ratio Adjusted odds ratio
f (%) f (%) OR (95 % CI) p value OR (95 % CI) p value
n = 77 n = 37
IL-1R(pst I 1970) CC 29(37.6) 9(24.3) 1 1
CT 41(53.2) 17(45.9) 1.3(0.52–3.4) 0.54 0.9(0.06–14.8) 0.99
TT 7(9.0) 11(29.8) 5.0(1.5–16.9) 0.08 19.9(0.6–577) 0.08
IL4R(+1902) AA 51(66.2) 17(46) 1 1
GA 22(28.6) 16(43) 2.1(0.93–5.0) 0.07 3.6(1.0–12.4) 0.48
GG 4(5.2) 4(11) 3(0.67–13.3) 0.14 21.8(3.2–148) 0.61
IL-1β(−511) CC 34(44.1) 9(24.4) 1 1
CT 27(35) 20(54) 2.7(1.0–7.1) 0.03 9.8(0.75–128.2) 0.08
TT 16(20.9) 8(21.6) 1.8(0.61–5.8) 0.26 3.2(0.09–114 0.51
TGF-β(codon25) CC 61(79.2) 26(70.27) 1 1
CG 14(18.2) 8(21.62) 1.3(0.50–3.6) 0.55 1.7(0.50–6.4) 0.37
GG 2(2.6) 3(8.1) 3.5(0.55–22.3) 0.18 15(1.5–141) 0.01
Adjusted odds ratio at 95 % CI of genotypes with ISS and SOFA score
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(Table 7). However, after adjusting odd ratio for SOFA
and ISS score at this position, using multivariate logistic
regression analysis, the frequency of GG genotype was
significantly (p = 0.01, OR(95 %) = 15 and CI = 1.5-141)
higher in non-survivors as compared with survivors
(Table 8).
Moreover, the distribution of haplotype of the TGF-β,
TNF-α, IL-2, IL-4, IL-6 and IL-10 genes were studied in
survivors and non-survivors (Table 9). A significant, dis-
tribution of haplotypes in TGF-β gene was observed sig-
nificant in both groups. The haplotype frequency of CT
in non-survivors (8.1 %) was significantly (p = 0.02)
higher in comparison to survivors (0 %) patients.
Estimation of serum cytokine levels in sepsis, non-sepsis
patients and healthy controls
Elevated levels of IL-1α, TNF-α and IL-10 were observed
in patients with sepsis compared to healthy controls and
non-sepsis patients (Table 10). CC genotype was the
higher producer of IL-1α compared to other genotypes
(Table 10). IL-1α was higher in the serum of sepsis (5.4 ±
2.8 vs. 18.6 ± 7.8 pg/ml, HC vs. sepsis, p < 0.05) than non-
sepsis (5.4 ± 2.8 vs. 7.2 ± 2.6 pg/ml, HC vs. non-sepsis).
Notably, a significantly higher level of TNF-α was found
in sepsis patients (25.7 ± 18.6 vs. 57.6 ± 18.7 pg/ml, HC vs.
sepsis, p < 0.001) than non-sepsis (25.7 ± 18.6 vs. 37.5 ±
16.8 pg/ml, HC vs. non-sepsis, p < 0.0001). The AA geno-
type of TNF-α (−308) and GA genotype of TNF-α (−238)
were found as the higher producer of cytokines. Interest-
ingly, GG genotype of IL-10 (−1082) was predominant in
sepsis patients and higher producer (11.6 ± 4.7 vs. 84.5 ±
37.5 pg/ml, HC vs. sepsis, p < 0.001).
Discussion
Genetic susceptibility of sepsis and the patients at high
risk of disease progression are still a matter of debate.
Deciphering genes involved in the host susceptibility or
resistance towards sepsis in trauma patients will allow
researchers to redefine the principles of pathogenesis of
sepsis and outcomes. Trauma patients present a state
where genetic variations in cytokine production dictate
various immune reactions and as a result, patients cor-
respond with different clinical outcomes. The present
study was conducted to explore the variation in cytokine
signature and susceptibility of post-trauma sepsis and
outcome.
The complexity of pathogenesis and the highly poly-
morphic nature of the inflammatory response as well as
genome make it extremely unlikely that an arbitrarily
selected candidate SNPs will prove to functionally sig-
nificant. To this end, we hypothesized that groups of
some SNPs in cytokine genes may work together to
Table 9 Distribution of Haplotype frequency in non-survivors and survivors patients
Cytokine gene Haplotypes Distribution of haplotype in survivors and non-survivors patients
Polymorphism Survivors Non-survivors χ2 p value
n (%) n (%)
TGF-β codon 10 C/T& codon25 G/C CG 65(84.4) 26(70.2)
CC 0(0) 3(8.1) 7.3 0.02
TG 12(15.6) 8(21.7)
TNF-α-308 G/A &-238 G/A GG 75(97.4) 34(91.9)
GA 1(1.3) 1(2.7) 1.9 0.22
AG 1(1.3) 2(5.4)
IL2 -330 T/G & + 160 G/T GG 18(23.3) 6(16.2)
TG 55(71.4) 19(78.4) 3.2 0.37
GT 0(0) 1(2.7)
TT 4(5.2) 1(2.7)
IL4-1098 T/G, −590 C/T & -590 C/T GCC 1(1.3) 1(2.7)
TCC 64(83.1) 26(70.3) 2.5 0.25
TTT 12(15.6) 10(27)
IL6-174 G/C & + 565 A/G GG 74(96.1) 36(97.3)
CG 1(1.3) 0(0) 0.48 0.99
GA 2(2.6) 1(2.7)
IL10 -1082 G/A, −819C/T &-592 C/A GCC 26(33.7) 12(32.4)
ACC 47(61.1) 24(64.8) 0.42 0.99
ATA 4(5.2) 1(2.8)
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influence the clinical outcome of major trauma patients
by regulating the cytokines levels. Under purview of this
hypothesis, we selected the 13 cytokines gene and 22
SNPs which are not only common polymorphism in
North Indian population, but also functional variations
expected to affect the outcome [20].
The main finding of this study is that SNPs of key
cytokines showed susceptibility to sepsis in trauma
patients, clinical outcomes and mortality that can be
used as markers of predisposition to sepsis. As for
clinical relevance, eight polymorphic loci IL-1α/-889, IL-
1β/-511, IL-1R (pstI 1970), TGF-β/ codon 25, TNF-α/-
308, TNF-α/-238, IL-6/+565, and IL-10/-1082 have been
shown to be significantly associated with sepsis morbid-
ity and outcome that may be used as a determinant of
risk factor for the outcome of trauma patients. Thus,
trauma patients were stratified into different groups
based on carriage of 22 SNPs and the above 8 risk SNPs,
respectively. There existed significant interaction among
SNPs in relation to the development of sepsis and organ
dysfunction in trauma patients in two cases of analysis.
The present study shows statistically significant associ-
ation between the genotype of TNF-α and the develop-
ment of sepsis and outcome. Subjects homozygous for
the allele A of TNF (−238) showed significantly higher
risk for the development of sepsis and have more chance
of death in the ICU. Compared to other studies, our
findings lead to similar results concerning the frequency
distribution of genotype and allele at TNF-α (−238)
SNPs [15, 21, 22]. Patients having heterozygous for the
allele TNF-308 G/A had a lower risk of developing
sepsis. In confirmation of this finding, we also observed
the distribution of haplotype at this position that are
produced due to combinations of genotypes-308 G/A
and −238 G/A. We observed those patients who had G
to A transition (G to A) had significantly higher risk of
developing sepsis and also had elevated serum levels of
TNF-α [23].
Interleukin-1 (IL-1) family is a critical mediator of im-
mune response to sepsis with two agonists (IL-1α and
IL-1β) and one antagonist (IL-1 receptor antagonist; IL-
1RA) [20, 24]. In this study, two polymorphisms (IL-1β
(−511) and IL-1R) were significantly associated with the
development of MOF and mortality where as IL-1α
(−889) polymorphism was associated with susceptibility
for sepsis. The results of our study revealed that individ-
uals with CC genotype at IL-1β (−511) had more
chances of developing MOF and also showed higher
mortality as compared to individuals of TT and CT. In
contrast, no association was observed for sepsis at this
position. This work is also supported by various studies
in mouse model of trauma, Caucasian and Chinese
population that indicated that IL-1β polymorphism are
associated with many diseases including inflammatory
bowel disease, rheumatoid arthritis and gastric cancer
[7, 24, 25]. To avoid inference from possible gender and
severity dependent differences in outcome following
trauma, adjusted odds ratio was calculated after adjust-
ment of gender, ISS and SOFA in sepsis and non-sepsis
patients. The heterozygous (TC) genotypes of IL-1 (−889)
showed independent risk factor for the susceptibility of
sepsis in trauma patients.
We have found an association between the IL-4
(−1098 T/G) polymorphism and susceptibility for sepsis
and outcomes. Similarly, IL-4R (+1902 A/G) polymorph-
ism and mortality was observed, but it failed to correlate
towards susceptibility for sepsis. The IL-4 gene poly-
morphism and susceptibility of various diseases like
Table 10 Showing the serum levels of IL-1α, TNF-α and IL-10 in healthy controls and patients
Genotype Healthy controls Non-sepsis Sepsis p Value
Percent pg/ml Percent pg/ml Percent pg/ml
IL-1α(−889) CC 48.5 5.4 ± 2.8 50.5 7.2 ± 2.6 84 18.6 ± 7.8 NS, pb<0.05, pc<0.05
CT 38.6 5.7 ± 1.9 35.9 8.3 ± 3.1 12 21.5 ± 8.7 NS, pb<0.05, pc<0.05
TT 12.9 3.7 ± 2.7 13.6 6.7 ± 2.7 4 16.2 ± 9.2 pa<0.05, pb<0.05, pc<0.05
TNF-α(−308) AA 2.8 25.7 ± 18.6 3.3 37.5 ± 16.8 8 57.6 ± 18.7 pa<0.05, pb<0.001, pc<0.001
GA 17.2 15.4 ± 9.7 19.1 34.6 ± 13.5 4 54.7 ± 19.6 pa<0.001, pb<0.001, pc<0.001
GG 80 11.2 ± 7.2 77.6 32.5 ± 12.7 88 51.2 ± 16.3 pa<0.05, pb<0.001, pc<0.0001
TNF-α(−238) GG 90 27.6 ± 16.7 87.7 35.2 ± 14.6 76 40.6 ± 23.5 pa<0.05, pb<0.001, pc<0.0001
GA 8.5 18.5 ± 12.3 11.2 30.5 ± 13.4 16 62.8 ± 18.6 pa<0.05, pb<0.001, pc<0.0001
AA 1.5 14.8 ± 7.8 1.1 32.4 ± 12.7 8 38.8 ± 14.8 pa<0.05, pb<0.001, pc<0.0001
IL-10(−1082) GG 7.1 11.6 ± 4.7 5.7 21.6 ± 13.5 16 84.5 ± 37.5 pa<0.01, pb<0.0001, pc<0.0001
GA 18.6 14.7 ± 5.2 37 22.5 ± 15.6 8 74.6 ± 26.3 pa<0.01, pb<0.001, pc<0.0001
AA 74.3 9.2 ± 4.5 57.3 16.7 ± 11.2 76 67.8 ± 21.4 pa<0.01, pb<0.001, pc<0.0001
p value (p < 0.05) considered as significant. It is calculated by two tailed Mann–Whitney, pa(healthy controls vs. non-sepsis),pb(healthy controls vs sepsis) and
pc(sepsis vs. non-sepsis)
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asthma and malaria were studied in Caucasian popula-
tion [26–28], but susceptibility of sepsis in trauma pa-
tients was showed by limited number of studies [27].
Moreover, we can’t conclude that the association of IL-4
and IL-4R polymorphism was linked with an unfavorable
prognosis of the syndrome because the functional rele-
vance of such variants on cytokine production is still
unknown.
High level of IL-10 secretion may be associated with
poor outcome after trauma, and identification of those
patients likely shows sensitivity to infection, may enable
novel targeted therapy in near future. Interestingly, we
noticed trauma patients who had (G to A) substitution
at IL-10(−1082) positions were protective for the sepsis
and produced significantly lower level of IL-10 in
comparison to GG genotype patients. Long et al. [9]
demonstrated that the −1082 A allele was significantly
associated with sepsis development after major trauma.
The study by Long et al. and other studies has clearly
demonstrated that the −1082 A/G polymorphism in the
IL-10 gene promoter has an important impact on sus-
ceptibility to sepsis and outcome. In contrast, we did not
observe significant difference for association between
the −819 and −592 polymorphism of IL-10 gene. The
present study also observed that the ATA haplotype was
significantly lower in sepsis patients in comparison to
non-sepsis. The gene encoding IL-10 cytokine involved
in the modulation of inflammatory responses as a main
anti-inflammatory agent is therefore a candidate gene
for determination of the human genetic background,
which is responsible for inter individual differences in
susceptibility to sepsis development.
The predominance of high producer genotype of TNF-
α with sepsis patients are not clear in this study. Inter-
estingly, the varied amount of TNF-α in all three groups:
healthy controls, non-sepsis and sepsis patients showed
an example of expression masking of the genotype with
a high producer genotype of IL-10 in these patients. In
other words degree of TNF-α in sepsis patients is associ-
ated with the production of IL-10. To avoid inference
from possible gender and severity dependent differences
in outcome following trauma, adjusted odds ratio was
calculated after adjustment of ISS and SOFA in survivors
and non-survivors patients. The GG genotype of TGF-β
(codon 25) was observed significantly three folds higher
in non-survivors (8.1 %) in comparison to survivors
(2.6 %) after adjusted with ISS and SOFA score. The dis-
tribution of genotypes at codon 25 and functional rele-
vance was not observed in this study. However, the
functional relevance of TGF-β gene polymorphism and
their relevance in the suseptability to Helicobacter pylori
related disease in known [29].
This study demonstrates to acknowledge for the first
time from India, that the genotype and alleles of the
cytokine genes is associated with susceptibility and out-
come. The IL-1β, TNF-α and IL-10 polymorphism fre-
quency was significantly higher in the post traumatic
septic group than in the non-sepsis and appeared to be
an independent risk factor for death due to septic shock.
We are aware that relatively small sample size limits our
study; a type II error may have occurred during analysis.
Moreover, selection bias cannot be excluded; even though
no differences of age, sex and ISS between groups were
observed, such selection bias may have contributed to dif-
ferences in cytokine levels at baseline and have affected
association results. Thus, it is not surprising that the
functional significance of some SNPs was not ob-
served. Nonetheless, the most significant and intri-
guing finding of our study still remains the significant
combined effect of cytokine gene SNPs on clinical
outcome of major trauma patients.
Conclusion
In conclusion, our study demonstrates that the alter-
nations in the genotype and allele frequency of IL-1β
(−511C/T), TNF-α (−308G/A), TNF-α (−238G/A) and
IL-10(−1082G/A) genes are associated with an in-
creased risk of sepsis development in major trauma
patients and outcomes. These associations support the
hypothesis that an increase in levels of IL-β, TNF-α
and IL-10 secretion due to genetic variation in their
genes may contribute to the development of sepsis
after severe trauma by affecting the induced immune
response. The results of this study need to be confirmed
in a large-scale prospective study from some other ethnic
populations, with encouraging further to develop
novel, perhaps individually-tailored, anti-inflammatory
therapies for the prevention of sepsis development
after major trauma.
Key message
1) This study demonstrates to acknowledge for the first
time from India, that the genotype and alleles of the
cytokine genes are associated with susceptibility for
sepsis and outcome.
2) As for clinical relevance, eight polymorphic loci
IL-1α /-889, IL-1β/-511, IL-1R (pstI 1970), TGF-β/
codon 10, TNF-α/-308, TNF-α/-238, IL-6/+565, and
IL-10/-1082 have been shown significantly associated
with sepsis morbidity and outcome and might be
used as risk determinant’s for the outcome of trauma
patients.
3) Our study showed an increase in levels of IL-β,
TNF-α and IL-10 secretion due to genetic variation
in their genes may contribute to the development of
sepsis after severe trauma by affecting the induced
immune response.
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4) The present study also observed that the ATA
haplotype of the IL-10 gene and CC haplotype of
TGF-β gene was significantly associated with sepsis
and outcome of trauma patients.
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